首页> 外文期刊>Biochemical Pharmacology >Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins
【24h】

Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins

机译:六种不同PPARγ蛋白六种不同PPARγ蛋白的新甲酮立体异构体和内源配体15d-PGJ2的新相互作用研究

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetes mellitus is a chronic disease characterized by hyperglycemia, insulin resistance and hyperlipidemia. Glitazones or thiazolidinediones (TZD) are drugs that act as insulin-sensitizing agents whose molecular target is the peroxisome proliferator-activated receptor gamma (PPAR gamma). The euglycemic action of TZD has been linked with the induction of type 4 glucose transporter. However, it has been shown that the effect of TZD depends on the specific stereoisomer that interacts with PPAR gamma. Therefore, this work is focused on exploring the interactions and geometry adopted by glitazone's stereoisomers and one endogenous ligand on different conformations of the six crystals of the PPAR gamma protein using molecular docking and molecular dynamics (MD) simulations accompanied by the MMGBSA approach. Specifically, the 2,4-thiazolidinedione ring, pioglitazone (PIO), rosiglitazone (ROSI) and troglitazone (TRO) stereoisomers (exogenous ligands), as well as the endogenous ligand 15d-PGJ2, were evaluated. The six crystallographic structures of PPAR gamma are available at Protein Data Bank as the PDB entries 2PRG, 4PRG, 3T03, 1171, 1FM6, and 4EMA. According to the results, a boomerang shape and a particular location of ligands were found with low variations according to the protein conformations. The 15d-PGJ2, TZD, PIO, ROSI and (S,S)-TRO enantiomers were mostly stabilized by twenty hydrophobic residues: Phe226, Pro227, Leu228, 11e281, Phe282, Cys285, Ala292, 11e296, 11e326, Tyr327, Met329, Leu330, Leu333, Met334, Va1339, 11e341, Met348, Leu353, Phe363 and Met364. Most hydrogen bond interactions were found between the polar groups of ligands with Arg288, Ser289, Lys367, G1n286, His323, G1u343 and His449 residues. An energetic analysis revealed binding free energy trends that supported known experimental findings of other authors describing better binding properties for PIO, ROSI and (S,S)-TRO than for 15d-PGJ2 and the TZD ring. (C) 2017 Elsevier Inc. All rights reserved.
机译:糖尿病是一种慢性疾病,其特征在于高血糖,胰岛素抵抗和高脂血症。 Gliitazones或噻唑烷二酮(TZD)是充当胰岛素敏化剂的药物,其分子靶标是过氧化物体增殖物激活的受体γ(PPARγ)。 TZD的Egycexy作用与4型葡萄糖转运蛋白的诱导有关。然而,已经表明TZD的效果取决于与PPARγ相互作用的特定立体异构体。因此,这项工作旨在探索Gritazone立体异构体和一个内源性配体采用的相互作用和几何形状,并使用MMGBSA方法伴随着MMGBSA方法的分子对接和分子动力学(MD)模拟的不同构象上的不同构象。具体地,评估2,4-噻唑烷二极管环,吡格列酮(PIO),Rosiglitazone(ROSI)和Troglitazone(TRO)立体异构体(外源配体)以及内源配体15d-PGJ2。 PPARγ的六个晶体结构可在蛋白质数据库中获得,作为PDB条目2prg,4prg,3t03,1171,1fm6和4ema。根据结果​​,在蛋白质构象的情况下,发现旋转形状和配体的特定位置。由20个疏水性残基(PHE226,PRO227,Leu228,1),PHE282,Cys285,Ala282,11E296,11E326,Tyr327,Met329,Leu330 ,Leu333,Met334,VA1339,11E341,Met348,Leu353,PHE363和Met364。在具有Arg288,Ser289,Lys367,G1N286,HIS323,G1U343和HIS449残基的配体的极性基团之间发现大多数氢键相互作用。能量分析显示了具有描述于PIO,ROSI和(S,S)-TRO比15d-PGJ2和TZD环的其他作者的已知实验结果的结合自由能趋势。 (c)2017年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号